HKD33.00
1.93% today
Hong Kong, Apr 03, 10:08 am CET
ISIN
KYG5074A1004
Symbol
6618
Index

JD Health International Target price 2025 - Analyst rating & recommendation

JD Health International Classifications & Recommendation:

Buy
71%
Hold
19%
Sell
10%

JD Health International Price Target

Target Price HKD40.42
Price HKD33.00
Potential
Number of Estimates 18
18 Analysts have issued a price target JD Health International 2026 . The average JD Health International target price is HKD40.42. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 21 analysts: 15 Analysts recommend JD Health International to buy, 4 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the JD Health International stock has an average upside potential 2026 of . Most analysts recommend the JD Health International stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Revenue Billion HKD 63.06 70.99
6.61% 12.58%
EBITDA Margin 2.37% 4.56%
47.72% 92.51%

19 Analysts have issued a sales forecast JD Health International 2025 . The average JD Health International sales estimate is

HKD71.0b
Unlock
. This is
12.58% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
HKD72.2b 14.57%
Unlock
, the lowest is
HKD67.3b 6.80%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 HKD63.1b 6.61%
2025
HKD71.0b 12.58%
Unlock
2026
HKD79.6b 12.17%
Unlock
2027
HKD88.3b 10.95%
Unlock
2028
HKD102b 15.00%
Unlock

10 Analysts have issued an JD Health International EBITDA forecast 2025. The average JD Health International EBITDA estimate is

HKD3.2b
Unlock
. This is
116.73% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
HKD4.1b 173.79%
Unlock
, the lowest is
HKD2.2b 48.48%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 HKD1.5b 57.48%
2025
HKD3.2b 116.65%
Unlock
2026
HKD4.1b 28.04%
Unlock
2027
HKD5.0b 19.83%
Unlock

EBITDA Margin

2024 2.37% 47.72%
2025
4.56% 92.51%
Unlock
2026
5.20% 14.04%
Unlock
2027
5.62% 8.08%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share HKD 1.44 1.22
89.47% 15.28%
P/E 27.55
EV/Sales 0.80

9 Analysts have issued a JD Health International forecast for earnings per share. The average JD Health International EPS is

HKD1.22
Unlock
. This is
14.08% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
HKD1.63 14.79%
Unlock
, the lowest is
HKD1.12 21.13%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 HKD1.44 89.47%
2025
HKD1.22 15.28%
Unlock
2026
HKD1.45 18.85%
Unlock
2027
HKD1.72 18.62%
Unlock
2028
HKD1.83 6.40%
Unlock

P/E ratio

Current 23.64 34.91%
2025
27.55 16.54%
Unlock
2026
23.26 15.57%
Unlock
2027
19.60 15.74%
Unlock
2028
18.35 6.38%
Unlock

Based on analysts' sales estimates for 2025, the JD Health International stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.90 23.29%
2025
0.80 11.36%
Unlock
2026
0.71 10.85%
Unlock
2027
0.64 9.87%
Unlock
2028
0.56 13.04%
Unlock

P/S ratio

Current 1.71 14.43%
2025
1.52 11.17%
Unlock
2026
1.35 10.85%
Unlock
2027
1.22 9.87%
Unlock
2028
1.06 13.04%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today